Literature DB >> 7326027

Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen.

J W Coleman, S T Holgate, M K Church, R C Godfrey.   

Abstract

A synthetic basic decapeptide from the C4 domain of human immunoglobulin E, corticotropin-(1-24)-peptide, polyarginine and polylysine stimulated up to 90% net release of 5-hydroxytryptamine from mast cells in rat peritoneal-cell suspensions. Concentration-response curves to all four polypeptides were parallel. Polyarginine and polylysine (EC50 congruent to 0.05 microM) were approximately 100-fold more potent than immunoglobulin E decapeptide and corticotropin-(1-24)-peptide (EC50 congruent to 5 microM). Polypeptide-induced release was complete within 5-10s. Immunoglobulin-E-decapeptide-induced 5-hydroxytryptamine release was additive to that induced by low concentrations of polyarginine, but non-additive to that induced by high concentrations of polyarginine. In contrast, release induced by antigen was additive along the whole length of the concentration-response curve to polyarginine. Benzalkonium chloride inhibited immunoglobulin-E-decapeptide- and polyarginine-induced 5-hydroxytryptamine release but enhanced release induced by immunological stimulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326027      PMCID: PMC1163309          DOI: 10.1042/bj1980615

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells.

Authors:  B Jasani; G Kreil; B F Mackler; D R Stanworth
Journal:  Biochem J       Date:  1979-09-01       Impact factor: 3.857

2.  Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine.

Authors:  D R Stanworth; M Kings; P D Roy; J M Moran; D M Moran
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

Review 3.  The IgE-mast cell system as a paradigm for the study of antibody mechanisms.

Authors:  H Metzger
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  Activation of rat mast cells by low molecular weight stimuli.

Authors:  D C Morrison; J F Roser; P M Henson; C G Cochrane
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Studies on the mast cell triggering action of certain artificial histamine liberators.

Authors:  B Jasani; D R Stanworth
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

Review 6.  Mechanisms of reaginic hypersensitivity and IgE antibody response.

Authors:  K Ishizaka; T Ishizaka
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

7.  The role of the antibody in immunological cell triggering processes.

Authors:  D R Stanworth
Journal:  Haematologia (Budap)       Date:  1974

8.  Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.

Authors:  G W Read; E F Kiefer
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

9.  Further studies on histamine release from rat mast cells in vitro induced by peptides. Characteristics of a synthetic intermediate with potent releasing activity.

Authors:  P D Roy; D M Moran; V Bryant; R Stevenson; D R Stanworth
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

10.  Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors.

Authors:  T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

View more
  11 in total

Review 1.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

Review 2.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

3.  The capacity of basic peptides to trigger exocytosis from mast cells correlates with their capacity to immobilize band 3 proteins in erythrocyte membranes.

Authors:  M J Dufton; R J Cherry; J W Coleman; D R Stanworth
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

4.  Improved surface-patterned platinum microelectrodes for the study of exocytotic events.

Authors:  Khajak Berberian; Kassandra Kisler; Qinghua Fang; Manfred Lindau
Journal:  Anal Chem       Date:  2009-11-01       Impact factor: 6.986

5.  Poly-L-arginine-mediated release of acetylcholine from parasympathetic nerves in rat and guinea-pig airways.

Authors:  D Spina; R G Goldie
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

6.  Contractile properties of synthetic cationic polypeptides in guinea-pig isolated trachea.

Authors:  D Spina; R G Goldie
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

7.  Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

Authors:  C R Beasley; P Rafferty; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

8.  The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

Authors:  K A Miszkiel; R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

9.  The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.

Authors:  K A Miszkiel; R Beasley; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

10.  Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A2 in a Rat Model.

Authors:  Bruna Stuqui; Marina de Paula-Silva; Carla Patrícia Carlos; Anwar Ullah; Raghuvir Krishnaswamy Arni; Cristiane Damas Gil; Sonia Maria Oliani
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.